ABBV-647
Showing 76 - 100 of 109
Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)
Progressive Supranuclear Palsy Trial in Worldwide (Placebo, ABBV-8E12)
Terminated
- Progressive Supranuclear Palsy
- Placebo
- ABBV-8E12
-
Birmingham, Alabama
- +65 more
Feb 1, 2021
Progressive Supranuclear Palsy (PSP) Trial in Worldwide (ABBV-8E12, Placebo solution for IV infusion on Day 15)
Terminated
- Progressive Supranuclear Palsy (PSP)
- ABBV-8E12
- Placebo solution for IV infusion on Day 15
-
Birmingham, Alabama
- +41 more
Feb 1, 2021
Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)
Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Eftozanermin alfa
- +2 more
-
Atlanta, Georgia
- +18 more
Oct 12, 2022
Crohn Disease Trial in Worldwide (Risankizumab 600 mg IV, Risankizumab 180 mg SC)
Completed
- Crohn Disease
- Risankizumab 600 mg IV
- Risankizumab 180 mg SC
-
Chevy Chase, Maryland
- +27 more
Apr 9, 2020
Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)
No longer available
- Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
- (no location specified)
Aug 16, 2019
Arthritis, Psoriatic Trial (risankizumab, for risankizumab)
Completed
- Arthritis, Psoriatic
- risankizumab
- placebo for risankizumab
- (no location specified)
May 28, 2019
Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)
Terminated
- Ovarian Cancer
- SC-003
- SC-003 in combination with ABBV-181
-
Fayetteville, Arkansas
- +15 more
Jan 2, 2019